Post-authorisation safety study to assess the risk of urinary tract cancer in people with type 2 diabetes initiating empagliflozin: a multi-country European study
Schmedt N, Alhamdow A, Tskhvarashvili G, et al.
Diabetes Obes Metab. Pub. online 13 Jun 2025.
Leggi